Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2008-08-12 22:57 2008-08-11 WST WEST PHARMACEUTICAL SERVICES INC LUZZI RICHARD D Officer SELL $49.21 4,200 $206,692 18,146
2008-08-12 17:35 2008-08-11 WST WEST PHARMACEUTICAL SERVICES INC ELLERS STEVEN A Officer SELL $49.14 10,000 $491,413 113,265
2008-08-11 17:52 2008-08-07 CRY Artivion Inc. Horton Amy Officer SELL $13.96 3,000 $41,880 30,171
2008-08-11 19:39 2008-08-08 OSUR ORASURE TECHNOLOGIES INC WATSON DOUGLAS G Director BUY $4.08 10,000 $40,838 10,000
2008-08-12 03:26 2008-08-07 CYTX PLUS THERAPEUTICS, INC. OLYMPUS CORP 10% owner BUY $6.00 1,000,000 $6,000,000 4,013,043
2008-08-11 21:52 2008-08-08 BDX BECTON DICKINSON & CO DURACK DAVID T Officer SELL $86.49 500 $43,245 250
2008-08-11 21:52 2008-08-07 BDX BECTON DICKINSON & CO KOZY WILLIAM A Officer OPT+S $85.05 27,141 $2,308,342 82,549
2008-08-11 23:05 2008-08-08 WST WEST PHARMACEUTICAL SERVICES INC HARGESHEIMER ROBERT S Officer OPT+S $48.89 8,500 $415,583 15,461
2008-08-08 23:22 2008-08-07 UFPT UFP TECHNOLOGIES INC ROCK MITCHELL Officer SELL $10.58 44,400 $469,752 83,120
2008-08-07 23:23 2008-08-05 ANGO Angiodynamics Inc. LaPorte Steve Director BUY $15.92 1,000 $15,920 3,013
2008-08-07 20:53 2008-08-07 OSUR ORASURE TECHNOLOGIES INC LANCASTER RONNY B Director BUY $4.04 20,000 $80,800 20,000
2008-08-07 23:37 2008-08-06 CRY Artivion Inc. FRONK DAVID Officer OPT+S $13.70 13,698 $187,630 32,090
2008-08-07 21:16 2008-08-05 CRY Artivion Inc. RONALD C ELKINS Director SELL $13.37 3,250 $43,467 66,250
2008-08-06 21:59 2008-08-05 CRY Artivion Inc. ANDERSON STEVEN G Director, Officer SELL $13.34 25,000 $333,605 1,061,824
2008-08-06 21:56 2008-08-04 BDX BECTON DICKINSON & CO DURACK DAVID T Officer SELL $84.88 250 $21,220 750
2008-08-04 23:22 2008-08-04 RMD RESMED INC FARRELL PETER C Director, Officer SELL $37.21 5,000 $186,050 842,672
2008-08-05 00:17 2008-08-01 PODD INSULET CORP Diehl R Anthony Officer OPT+S $14.00 1,500 $21,000 12,670
2008-08-01 17:36 2008-07-31 MMM 3M CO NOZARI M S Officer SELL $70.87 20,000 $1,417,350 77,222
2008-07-31 00:00 2008-07-29 MMSI MERIT MEDICAL SYSTEMS INC Miller Franklin J Director OPT+S $20.39 10,050 $204,887 1,867
2008-07-30 21:44 2008-07-28 BSX BOSTON SCIENTIFIC CORP MCCONNELL WILLIAM F JR Officer SELL $11.91 20,000 $238,200 43,804
2008-07-30 23:56 2008-07-29 MMSI MERIT MEDICAL SYSTEMS INC STILLABOWER MICHAEL E Director OPT+S $20.41 27,777 $566,862 22,222
2008-07-29 22:59 2008-07-25 MMSI MERIT MEDICAL SYSTEMS INC PERRY RASHELLE Officer OPT+S $19.65 29,155 $572,896 1,566
2008-07-28 23:12 2008-07-25 BSX BOSTON SCIENTIFIC CORP GROVES RAY J Director BUY $12.23 10,000 $122,300 19,167
2008-07-25 15:16 2008-07-24 SYK STRYKER CORP FRANCESCONI LOUISE Director BUY $64.49 1,000 $64,485 5,000
2008-07-24 21:05 2008-07-23 SYK STRYKER CORP FRANCESCONI LOUISE Director BUY $64.47 2,000 $128,940 4,000
2008-07-23 23:54 2008-07-21 BAX BAXTER INTERNATIONAL INC MARTIN JOSEPH B Director OPT+S $68.46 7,500 $513,447 2,027
2008-07-23 00:41 2008-07-22 HAE HAEMONETICS CORP NUTTER BRAD Director, Officer OPT+S $55.00 50,000 $2,750,000 5,000
2008-07-23 03:22 2008-07-18 MELA STRATA Skin Sciences, Inc. BONANZA CAPITAL LTD 10% owner SELL $6.55 49,208 $322,312 1,524,787
2008-07-18 16:30 2008-05-23 MELA STRATA Skin Sciences, Inc. Cheng-Avery Tina Officer BUY $7.76 8,000 $62,119 8,000
2008-07-17 20:57 2008-07-15 CRY Artivion Inc. SEERY GERALD B Officer OPT+S $10.58 5,500 $58,210 19,335
2008-07-12 00:24 2008-07-09 MELA STRATA Skin Sciences, Inc. BONANZA CAPITAL LTD 10% owner SELL $7.16 57,598 $412,407 1,573,995
2008-07-12 00:05 2008-07-09 BAX BAXTER INTERNATIONAL INC GATLING JAMES M Officer OPT+S $66.00 28,220 $1,862,520 139,688
2008-07-09 20:31 2008-07-07 RMD RESMED INC FARRELL PETER C Director, Officer SELL $38.13 5,000 $190,650 814,054
2008-07-10 03:50 2008-07-07 MELA STRATA Skin Sciences, Inc. BONANZA CAPITAL LTD 10% owner SELL $7.75 2,992 $23,188 1,631,593
2008-07-03 22:33 2008-07-01 MELA STRATA Skin Sciences, Inc. BONANZA CAPITAL LTD 10% owner SELL $7.75 12,315 $95,441 1,634,585
2008-07-02 23:31 2008-07-01 PODD INSULET CORP Diehl R Anthony Officer OPT+S $15.52 1,500 $23,280 12,670
2008-07-01 23:40 2008-06-30 HAE HAEMONETICS CORP Pare Anthony OPT+S $57.40 500 $28,700 2,523
2008-07-01 02:42 2008-06-27 STEM Microbot Medical Inc. WEISSMAN IRVING Director SELL $1.20 80,000 $96,216 814,062
2008-06-30 23:53 2008-06-26 PDII INTERPACE BIOSCIENCES, INC. Smith Jeffrey Edward Officer BUY $8.26 6,054 $50,006 38,232
2008-07-01 02:41 2008-06-26 MELA STRATA Skin Sciences, Inc. BONANZA CAPITAL LTD 10% owner SELL $7.76 15,700 $121,799 1,646,900
2008-06-28 00:21 2008-06-25 BAX BAXTER INTERNATIONAL INC GATLING JAMES M Officer OPT+S $63.00 36,792 $2,317,896 139,688
2008-06-26 02:39 2008-06-23 MELA STRATA Skin Sciences, Inc. BONANZA CAPITAL LTD 10% owner SELL $8.12 111,600 $905,701 1,662,600
2008-06-20 04:22 2008-06-13 ATEC Alphatec Holdings, Inc. Garner Ebun Officer BUY $4.40 350 $1,540 34,914
2008-06-18 19:08 2008-06-09 ATRC AtriCure, Inc. Collar Mark A Director BUY $10.41 2,000 $20,828 2,000
2008-06-18 23:48 2008-06-16 STEM Microbot Medical Inc. SCHWARTZ JOHN J Director OPT+S $1.37 47,700 $65,492 0
2008-06-17 17:02 2008-06-13 TFX TELEFLEX INC COOK WILLIAM ROLAND Director OPT+S $58.79 2,795 $164,307 8,477
2008-06-17 19:41 2008-06-16 HAE HAEMONETICS CORP NUTTER BRAD Director, Officer OPT+S $57.13 50,000 $2,856,330 5,000
2008-06-17 23:27 2008-06-13 IART INTEGRA LIFESCIENCES HOLDINGS CORP HENNEMAN JOHN B III Officer OPT+S $44.89 10,000 $448,926 28,072
2008-06-17 20:34 2008-06-16 CRY Artivion Inc. SEERY GERALD B Officer OPT+S $10.80 5,500 $59,406 19,335
2008-06-17 21:20 2008-06-16 CRY Artivion Inc. RONALD C ELKINS Director SELL $10.96 1,000 $10,958 69,500
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.